Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on COP. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110590621B details a mild copper-catalyzed route for 1,2-bis(arylsulfonyl) ethylene derivatives, offering cost reduction and scalable manufacturing for fine chemical intermediates.
Patent CN111410656B details a novel copper-catalyzed route to isoquinolinones, offering cost reduction in pharmaceutical intermediate manufacturing and scalable production capabilities.
Patent CN110204487B reveals a green synthesis of quinoline derivatives using cheap copper catalysts, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN110028448B details a cost-effective copper-catalyzed synthesis of 3-hydroxy-2,3-dihydroisoquinoline-1,4-dione intermediates, offering significant supply chain advantages.
Patent CN110183378A reveals high-yield catalytic route for nicotinamide derivatives ensuring supply chain stability and cost efficiency for pharmaceutical manufacturing.
Novel basic copper fluoride catalyst enables room temperature synthesis of benzil derivatives. Reduces heavy metal reliance for pharmaceutical intermediate manufacturing supply chains.
Patent CN111018807B reveals a novel copper-catalyzed route for 1,2,4-thiadiazole derivatives, offering cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Novel copper-catalyzed route for furo[2,3-b]quinoxaline derivatives offering high purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN110003081B details a copper-catalyzed route to polyfluoroalkyl indolines, offering cost-effective alternatives to palladium methods for pharmaceutical intermediate manufacturing.
Patent CN110483387B reveals a novel one-pot synthesis for 2,N,4,5,6-pentasubstituted nicotinamide derivatives, offering high yields and simplified purification for pharmaceutical intermediate manufacturing.
Patent CN116478052B reveals copper-catalyzed synthesis for high-purity 1-naphthylamine derivatives. Offers scalable production and cost reduction for pharmaceutical intermediate manufacturing supply chains.
Patent CN101792438A details a copper-catalyzed decarboxylative coupling for high-purity triazole intermediates, offering cost-effective manufacturing solutions.
Patent CN107602452B reveals a one-pot copper-catalyzed method for 3-acyl pyridines, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel copper-catalyzed route for high-purity quinazolinone intermediates. Enhanced yield and fluorescence sensing applications for industrial procurement and supply chain stability.
Patent CN113845481A details a copper-catalyzed route to pyridazinone intermediates, offering safer alternatives to hydrazine for reliable pharmaceutical manufacturing.
This patent details a copper-catalyzed synthesis for 1-naphthylamine derivatives offering high yields. It enables cost reduction and scalable manufacturing for reliable pharmaceutical intermediate suppliers globally.
Novel one-pot synthesis for 9H-pyrimido[4,5-b]indoles using copper catalysis. Reduces steps and cost for pharmaceutical intermediates.
Patent CN114160206B reveals a novel chiral copper catalyst for optically active indoles. Achieve >91% ee and substantial cost reduction in API manufacturing with scalable processes.
Patent CN108467376A reveals copper-catalyzed water-phase synthesis offering significant cost reduction and supply chain reliability for high-purity dibenzofuran derivative manufacturing.
Patent CN114195726B enables efficient arylamine production. Reduces cost and improves supply chain reliability for pharma intermediates.